Posted on 6/21/18
Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks
If you own Johnson & Johnson (NYSE:JNJ) stock, there's a really good chance that you do so because of its dividend. The healthcare giant is a . . .
Posted on 6/21/18
ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
EDISON, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 6/20/18
Klick Health wins two Cannes Lions Health Awards
TORONTO & NEW YORK--(BUSINESS WIRE)--Klick Health today announced it has won a pair of Cannes Lions Health Awards at the 2018 Cannes Lions International Festival of . . .
Posted on 6/20/18
Buy Johnson & Johnson
Over the last number of months, bonds have been dropping and yields have been rising. As such, many of the more defensive stocks that trade along . . .
Posted on 6/20/18
Better Buy: Celgene Corporation vs. Merck
A series of setbacks caused Celgene Corporation (NASDAQ:CELG) stock to tumble around 47% from a peak reached last October. Over the same time frame, Merck & . . .
Posted on 6/19/18
Matinas BioPharma Prices $8.0 Million Public Offering
BEDMINSTER, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines . . .
Posted on 6/19/18
Kallyope and Novo Nordisk Announce Collaboration
Kallyope Inc. and Novo Nordisk A/S today announced that they have entered into a research collaboration and option agreement to discover novel peptide therapeutics to treat . . .
Posted on 6/19/18
MetLife Social Impact Investments Rise to $50 Billion
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE:MET) today announced its impact investment portfolio grew to $50 billion in 2017, an increase of 12 percent year-over-year from 2016 to . . .
Posted on 6/19/18
CVS And Aetna Are Changing The Healthcare Paradigm
Market OutlookWith the recent proposed purchase of Aetna (NYSE:AET), CVS (NYSE:CVS) has positioned itself as the only player in the market with such a significant market . . .
Posted on 6/19/18
Here's Why PTC Therapeutics Is Soaring While Biogen and Ionis Struggle
What happenedShares of PTC Therapeutics (NASDAQ:PTCT) are up 24.6% at 12:40 p.m. EDT after PTC and partner Roche (NASDAQOTH:RHHBY) presented data on their spinal muscular atrophy . . .
Posted on 6/18/18
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates
EDISON, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 6/18/18
New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken
Using Single-Use Bronchoscopes Could Significantly Reduce the Risk of Life-threatening Infection Transmission Among PatientsBronchoscopy is one of the most common interventional pulmonology procedures and most practitioners . . .
Posted on 6/18/18
Champions Oncology Partners with Puma Biotechnology and NSABP Foundation
Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced . . .
Posted on 6/18/18
Stealth BioTherapeutics Closes $100M Financing
Stealth BioTherapeutics, a clinical-stage biopharmaceutical company developing a first-in-class platform of novel therapeutic compounds for the treatment of mitochondrial dysfunction, today announced the closing of an . . .
Posted on 6/18/18
Should You Buy Celgene Stock?
A trial failure, disappointing long-term guidance, and an embarrassing stumble at the FDA's finish line have erased billions of dollars from Celgene Corp.'s (NASDAQ:CELG) market cap . . .
Posted on 6/18/18
Better Buy: Pfizer Inc. vs. Johnson & Johnson
The two biggest U.S.-based drugmakers are household names. Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) have been in business since the 19th century. Both big pharma . . .
Posted on 6/18/18
Better Buy: Johnson & Johnson vs. Eli Lilly
Investors couldn't go wrong choosing between Johnson & Johnson (NYSE:JNJ) and Eli Lilly and Co. (NYSE:LLY) a decade ago. Over the past 10 years, the big . . .
Posted on 6/18/18
Ortho Clinical Diagnostics Named Transatlantic Legal Department of the Year by Panel of Leading Legal Journalists
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that its in-house Legal and Compliance Department has been named the Transatlantic Legal . . .
Posted on 6/17/18
Immunomedics Closes Public Offering of Common Stock
MORRIS PLAINS, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced the . . .
Posted on 6/15/18
Finger-Pointing At Celgene
Just what is going on at Celgene (NASDAQ:CELG)? They've had some odd recent setbacks (such as the failure of Mongersen), and another such acquisition, Ozanimod, had . . .
Posted on 6/15/18
Kadmon Closes $113.2 Million Offerings of Common Stock
NEW YORK--(BUSINESS WIRE)--Kadmon Holdings, Inc. (NYSE:KDMN) today announced the closing of its previously announced offerings of common stock for gross proceeds of approximately $113.2 million, which . . .
Posted on 6/14/18
CitiusTech Named to Healthcare Informatics Top 100 List for Third Consecutive Year
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, has been ranked 75th in the 2018 Healthcare Informatics (HCI) 100 list. Every year . . .
Posted on 6/14/18
MetLife and Insurtech Start-Ups Ignite Innovation
NEW YORK--(BUSINESS WIRE)--How does a digital start-up get the attention of a Fortune 50 insurer with more than $60 billion in revenue? At MetLife, they walk . . .
Posted on 6/14/18
Ambra Health Named Winner of 2018 SIIA Business Technology CODiE Award in Best Healthcare Technology Solution Category
Ambra Health, makers of the leading cloud-based, medical image management suite, today announced the company was named a 2018 SIIA CODiE Award winner in the Best . . .
Posted on 6/14/18
Apexigen and Yale Cancer Center Announce Clinical Collaboration
Apexigen, Inc., and Yale Cancer Center today announced a clinical trial collaboration to evaluate Apexigen's APX005M in combination with cabiralizumab and Opdivo in patients with advanced . . .

